CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month for a limited time.

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences with the drug.

Apparel retailers could see an up to $13 billion annual boost in spending because of GLP-1 drugs, according to an estimate by equity research firm Bernstein.